tirzepatide phase 3 study results on ingestive behavior in adults with overweight or obesity: a randomized 6-week 1 trial obesitymedicine #glp1 #amylin #cagrisema #tirzepatide

Avoid clinics in Iowa that pressure you into long-term contracts

The SUSTAIN and SELECT trials demonstrated that GLP-1 treatment independently lowers cardiovascular events, meaning patients on both aspirin and semaglutide benefit from dual cardioprotection

Fibroblasts, stem cells, and immune cells need to reach the damaged tissue

This cautious approach allows the body to recognize the medication and begin the adaptation process with minimal stress

Weight loss is usually gradual, and steady progress is often more sustainable

Increased satiety: It can help you feel fuller longer, reducing the urge to overeat or snack between meals